Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities
Trends in Pharmacological Sciences · 2026
DOI: 10.1016/j.tips.2026.02.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026. Verfasst von Nemat Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Khalifa University, Abu Dhabi, United Arab Emirates; Centre for Biotechnology, Khalifa University, Abu Dhabi, United …. Hauptthemen laut MEDLINE: Multiple Sclerosis, Complement System Proteins, Complement Inactivating Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khalifa University, National Health and Medical Research Council.
Abstract (Originalsprache)
The complement system is a conserved network of plasma and membrane-associated proteins that supports immune defense and tissue homeostasis. In multiple sclerosis (MS), persistent complement activation contributes to neuroinflammation, demyelination, and axonal injury. However, the translation of complement-targeted therapies for MS treatment has been limited, largely due to uncertainty surrounding the complex and context-dependent roles of complement pathways within the central nervous system. This review integrates the latest preclinical and clinical insights to delineate pathogenic and reparative complement pathways and to support the stratification of MS phenotypes using complement biomarkers and signatures. We further review approved and emerging complement inhibitors with neurological relevance, focusing on their translational implications for MS. Together, this integrated framework may guide the rational design of future complement-targeted MS trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Khalifa University, Abu Dhabi, United Arab Emirates; Centre for Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates; School of Biomedical Sciences, Faculty of Health, Medic…
- Department of Molecular Medicine, Jamia Hamdard, New Delhi, India.
- Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
- School of Biomedical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.
Förderung
- Khalifa University
- National Health and Medical Research Council
Zitieren
APA
Khan, N., Zakriya, Z. M., McCombe, P., & Woodruff, T. M. (2026). Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2026.02.006
Vancouver
Khan N, Zakriya ZM, McCombe P, Woodruff TM. Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities. Trends in Pharmacological Sciences. 2026. doi:10.1016/j.tips.2026.02.006
BibTeX
@article{Khan2026,
author = {Khan, Nemat and Zakriya, Zikra M and McCombe, Pamela and Woodruff, Trent M},
title = {Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities},
journal = {Trends in Pharmacological Sciences},
year = {2026},
doi = {10.1016/j.tips.2026.02.006}
}
EUVIMED